Reduced expression of death-associated protein kinase in human uterine and ovarian carcinoma cells
- PMID: 14767518
Reduced expression of death-associated protein kinase in human uterine and ovarian carcinoma cells
Abstract
The expression of the death-associated protein kinase (DAPK) protein and promoter methylation in 11 human uterine and ovarian carcinoma cell lines originally established from histopathologically-different carcinoma tissues were examined to investigate the relationship between DAPK and carcinogenesis in female reproductive tissues. The 11 cell lines included three cervical carcinomas, three endometrial carcinomas and five ovarian carcinomas. Western blot analysis showed no detectable expression of DAPK protein in 4 cell lines (ME180, HOKUG, MCAS and OVK-18) while moderate levels of DAPK protein were readily detected in normal human endometrium, and normal murine uterus and ovary. Methylation-specific PCR of the 11 cell lines revealed that 5 carcinoma cell lines (ME180, HOKUG, MCAS, OVK-18 and HEC-1) expressed hypermethylated promoters in the DAPK genes, while DAPK promoters in the other 6 carcinoma cell lines remained unmethylated. These results indicate that DAPK protein expression is reduced or silenced in some human uterine and ovarian carcinoma cells by methylation of the DAPK gene promoter region. Therefore, reduced DAPK expression and methylation of the DAPK promoter may be involved in carcinogenesis of human uterine and ovarian tissues.
Similar articles
-
Radiation-induced cell death is independent of the apoptotic signals mediated by death-associated protein kinase in human cervical squamous cell carcinoma cells.Oncol Rep. 2005 Oct;14(4):949-55. Oncol Rep. 2005. PMID: 16142356
-
Methylation-associated silencing of death-associated protein kinase gene in laryngeal squamous cell cancer.Laryngoscope. 2005 Aug;115(8):1395-401. doi: 10.1097/01.MLG.0000166708.23673.3A. Laryngoscope. 2005. PMID: 16094112
-
Promoter methylation of death-associated protein kinase and its role in irradiation response in cervical cancer.Oncol Rep. 2008 May;19(5):1339-45. Oncol Rep. 2008. PMID: 18425396
-
DAPk protein family and cancer.Autophagy. 2006 Apr-Jun;2(2):74-9. doi: 10.4161/auto.2.2.2459. Autophagy. 2006. PMID: 17139808 Review.
-
Transcription control of DAPK.Apoptosis. 2014 Feb;19(2):298-305. doi: 10.1007/s10495-013-0931-6. Apoptosis. 2014. PMID: 24217921 Review.
Cited by
-
Association of diminished expression of RASSF1A with promoter methylation in primary gastric cancer from patients of central China.BMC Cancer. 2007 Jul 3;7:120. doi: 10.1186/1471-2407-7-120. BMC Cancer. 2007. PMID: 17608924 Free PMC article.
-
Control of death-associated protein kinase (DAPK) activity by phosphorylation and proteasomal degradation.J Biol Chem. 2006 Dec 22;281(51):39033-40. doi: 10.1074/jbc.M605097200. Epub 2006 Oct 20. J Biol Chem. 2006. PMID: 17056602 Free PMC article.
-
Epigenetic regulation of cancer-associated genes in ovarian cancer.Int J Mol Sci. 2011 Jan 31;12(2):983-1008. doi: 10.3390/ijms12020983. Int J Mol Sci. 2011. PMID: 21541038 Free PMC article. Review.
-
MicroRNA-520g promotes epithelial ovarian cancer progression and chemoresistance via DAPK2 repression.Oncotarget. 2016 May 3;7(18):26516-34. doi: 10.18632/oncotarget.8530. Oncotarget. 2016. PMID: 27049921 Free PMC article.
-
Influence of HRH2 promoter polymorphism on aberrant DNA methylation of DAPK and CDH1 in the gastric epithelium.BMC Gastroenterol. 2013 Jan 2;13:1. doi: 10.1186/1471-230X-13-1. BMC Gastroenterol. 2013. PMID: 23280118 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials